These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 39042875)

  • 1. Deprescribing as a Way to Reduce Inappropriate Use of Drugs for Overactive Bladder in Primary Care (DROP): Protocol for a Cluster Randomized Controlled Trial With an Embedded Explanatory Sequential Mixed Methods Study.
    Soerensen AL; Haase Juhl M; Krogh ML; Grønkjær M; Kristensen JK; Olesen AE
    JMIR Res Protoc; 2024 Jul; 13():e56277. PubMed ID: 39042875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the Efficacy of the ARMOR Tool-Based Deprescribing Intervention for Fall Risk Reduction in Older Patients Taking Fall Risk-Increasing Drugs (DeFRID Trial): Protocol for a Randomized Controlled Trial.
    Priyadarshini R; Eerike M; Varatharajan S; Ramaswamy G; Raj GM; Cherian JJ; Rajendran P; Gunasekaran V; Rao SV; Konda VGR
    JMIR Res Protoc; 2024 Jun; 13():e55638. PubMed ID: 38861709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a multi-faceted intervention to deprescribe proton pump inhibitors in primary care: protocol for a population-based, pragmatic, cluster-randomized controlled trial.
    Nguyen-Soenen J; Rat C; Gaultier A; Schirr-Bonnans S; Tessier P; Fournier JP
    BMC Health Serv Res; 2022 Feb; 22(1):219. PubMed ID: 35177042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A process evaluation of a cluster randomised trial to reduce potentially inappropriate prescribing in older people in primary care (OPTI-SCRIPT study).
    Clyne B; Cooper JA; Hughes CM; Fahey T; Smith SM;
    Trials; 2016 Aug; 17(1):386. PubMed ID: 27488272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a deprescribing tool on the use of sedative hypnotics among older patients: study protocol for a cluster randomised controlled trial in Swiss primary care (the HYPE trial).
    Weiss K; Pichierri G; Grischott T; Groth S; Neuner-Jehle S
    BMJ Open; 2023 Sep; 13(9):e075828. PubMed ID: 37730388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a multicomponent communication training to involve older people in decisions to DEPRESCRIBE cardiometabolic medication in primary care (CO-DEPRESCRIBE): protocol for a cluster randomized controlled trial with embedded process and economic evaluation.
    Stuijt PJC; Heringa M; van Dijk L; Faber A; Burgers JS; Feenstra TL; Taxis K; Denig P
    BMC Prim Care; 2024 Jun; 25(1):210. PubMed ID: 38862899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cluster-randomized trial of a complex intervention to encourage deprescribing antidepressants in nursing home residents with dementia: a study protocol.
    Hølmkjær P; Holm A; Overbeck G; Rozing MP
    Trials; 2022 May; 23(1):410. PubMed ID: 35578351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial.
    Nadeau ME; Henry JL; Lee TC; Bortolussi-Courval É; Goodine C; McDonald EG
    Trials; 2021 Nov; 22(1):763. PubMed ID: 34727956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family conferences and shared prioritisation to improve patient safety in the frail elderly (COFRAIL): study protocol of a cluster randomised intervention trial in primary care.
    Mortsiefer A; Wilm S; Santos S; Löscher S; Wollny A; Drewelow E; Ritzke M; Thürmann P; Mann NK; Meyer G; Abraham J; Icks A; Montalbo J; Wiese B; Altiner A;
    Trials; 2020 Mar; 21(1):285. PubMed ID: 32197631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A deprescribing programme aimed to optimise blood glucose-lowering medication in older people with type 2 diabetes mellitus, the OMED2-study: the study protocol for a randomised controlled trial.
    Andriessen C; Blom MT; van Hoek BACE; de Boer AW; Denig P; de Wit GA; Swart K; de Rooij-Peek A; van Marum RJ; Hugtenburg JG; Slottje P; van Raalte D; van Bloemendaal L; Herings R; Nijpels G; Vos RC; Elders PJM
    Trials; 2024 Jul; 25(1):505. PubMed ID: 39049109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
    Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
    Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient and general practitioner experiences of implementing a medication review intervention in older people with multimorbidity: Process evaluation of the SPPiRE trial.
    McCarthy C; Pericin I; Smith SM; Kiely B; Moriarty F; Wallace E; Clyne B
    Health Expect; 2022 Dec; 25(6):3225-3237. PubMed ID: 36245339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy: The COFRAIL Cluster Randomized Trial.
    Mortsiefer A; Löscher S; Pashutina Y; Santos S; Altiner A; Drewelow E; Ritzke M; Wollny A; Thürmann P; Bencheva V; Gogolin M; Meyer G; Abraham J; Fleischer S; Icks A; Montalbo J; Wiese B; Wilm S; Feldmeier G
    JAMA Netw Open; 2023 Mar; 6(3):e234723. PubMed ID: 36972052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving care for elderly patients living with polypharmacy: protocol for a pragmatic cluster randomized trial in community-based primary care practices in Canada.
    Greiver M; Dahrouge S; O'Brien P; Manca D; Lussier MT; Wang J; Burge F; Grandy M; Singer A; Twohig M; Moineddin R; Kalia S; Aliarzadeh B; Ivers N; Garies S; Turner JP; Farrell B
    Implement Sci; 2019 Jun; 14(1):55. PubMed ID: 31171011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving inappropriate medication and information transfer at hospital discharge: study protocol for a cluster RCT.
    Grischott T; Zechmann S; Rachamin Y; Markun S; Chmiel C; Senn O; Rosemann T; Rodondi N; Neuner-Jehle S
    Implement Sci; 2018 Dec; 13(1):155. PubMed ID: 30591069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care.
    Palagyi A; Keay L; Harper J; Potter J; Lindley RI
    BMC Geriatr; 2016 Jan; 16():15. PubMed ID: 26767619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues with deprescribing in haemodialysis: a qualitative study of patient and provider experiences.
    Bondurant-David K; Dang S; Levy S; Sperlea D; Vanier MC; Gerardi S; David PM
    Int J Pharm Pract; 2020 Dec; 28(6):635-642. PubMed ID: 33094884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deprescribing Medications Among Older Adults From End of Hospitalization Through Postacute Care: A Shed-MEDS Randomized Clinical Trial.
    Vasilevskis EE; Shah AS; Hollingsworth EK; Shotwell MS; Kripalani S; Mixon AS; Simmons SF
    JAMA Intern Med; 2023 Mar; 183(3):223-231. PubMed ID: 36745422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.